Skip to main content
UK clinical trials - updated daily from ClinicalTrials.gov
TrialConnect
← Back to Search
UNKNOWNN/A

A Game-based Neurodevelopmental Assessment for Young Children

Sponsor: Brightlobe Limited

NCT ID: NCT05780853

View on ClinicalTrials.gov ↗

At a glance

What the study gets you
Health checks and monitoring — no treatment given
Type of study
Observational (no treatment given)
Time in hospital
In-person visits at study sites — visit count not specified by the sponsor
Drug or intervention
Tablet Game-based Assessment - YARN assessment service (diagnostic test), Adaptive Behavior Assessment System, Third Edition (ABAS-3) (diagnostic test), Demographic questionnaire (other)
How long the study runs
Study runs about 41 months (dates as stated)
About the drug or intervention
Tablet Game-based Assessment - YARN assessment service — diagnostic test: Tablet game-based assessment to assess neurodevelopmental profile. · Adaptive Behavior Assessment System, Third Edition (ABAS-3) — diagnostic test: A parent-reported child behavioural assessment questionnaire used to diagnose and classify various developmental, learning and behavioural disabilities and disorders. · Demographic questionnaire — other: Parent/carer and child's demographic data such as age, ethnicity, employment status, household income, medical history and education status.
Patient visit burden
Not specified by the sponsor
Type of study
Observing health over time
Ages
3 Years to 8 Years
Who
All
Number of participants
590
Started
2023-01-30
Last checked
2024-07

Plain English Summary

What is this study?

  • • Testing a new treatment for neurodevelopmental disorders
  • • Clinical study - 590 participants
  • • The aim of this study is to evaluate a novel tablet game-based neurodevelopmental assessment tool for young children aged 3 to 8 years old

Who can take part?

  • • Ages 3 Years to 8 Years
  • • Diagnosed with neurodevelopmental disorders

Where?

  • • London - Brightlobe Limited

This is a simplified summary. Always discuss with your doctor before making any decisions.

About This Trial

The aim of this study is to evaluate a novel tablet game-based neurodevelopmental assessment tool for young children aged 3 to 8 years old. The study's main aims are: (1) to determine whether the novel tablet-game based assessment tool can accurately differentiate children's neurodevelopmental status based on their performance on the game and (2) assess the validity of the game-based neurodevelopment assessment tool. The study aims to recruit 590 children who are 'typically' developing and/or have a diagnosed neurodevelopmental disorder including Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), Specific Learning Disorder, or a Communication Disorder. All participants will complete the tablet game-based assessment which aims to assess a range of neuropsychological functions including attention, memory, language, motor, executive functions and social-emotional skills. Parents/carers of participants will also complete a demographic questionnaire and the Adaptive Behaviour System - Third Edition (ABAS-3), which is a questionnaire that assesses a child's development. Some participants will be re-tested on the tablet game-based assessment approximately 2 weeks after the first tablet game-based assessment to ensure the game's validity.

Neurodevelopmental DisordersAutism Spectrum DisorderAttention Deficit Hyperactivity DisorderDyslexiaSpecific Learning DisorderChild Development

How this trial compares with your answers

Answer 2 more questions to improve match

What we know so far

Condition· Matched your search
Age· Tell us your age for better matching
Gender· Tell us your sex for better matching

Still need:

  • • Tell us your age for better matching
  • • Tell us your sex for better matching

Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.

Eligibility at a Glance

Key info

  • Age: 3 Years - 8 Years
  • Who can join: All genders

What the study is looking for

  • ✓3 to 8 year old 'typically' developing children with no known neurodevelopmental disorder.
  • ✓All parents/caregivers and children must have a minimum level of English fluency required to complete the parent...

Who cannot take part

  • ✗Children with medical other health conditions, a chronic illness or any additional diagnoses that would impact their ability...
See the full criteria
Inclusion Criteria: * 3 to 8 year old 'typically' developing children with no known neurodevelopmental disorder. OR * 3 to 8 year old children with a diagnosed neurodevelopmental disorder, including Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), Specific Learning Disorder, or a Communication Disorder. All parents/caregivers and children must have a minimum level of English fluency required to complete the parent questionnaire and the game-based assessment. Exclusion Criteria: * Children with medical comorbidities, a chronic illness or any additional diagnoses that would impact their ability to complete the game-based assessment.

Where Is This Study? (1 UK site)

Brightlobe Limited

London, United Kingdom

Recruiting
Site contact (verified)

How to Get in Touch

Shivani Lamba

Sponsor contact

CONTACT

+447872989457 study@brightlobe.com
Data sourced from ClinicalTrials.gov · Last verified: 2024-07